Chemotaxis and chemokinesis of malignant mesothelioma cells to multiple growth factors - PubMed (original) (raw)
. 2004 May-Jun;24(3a):1625-30.
Affiliations
- PMID: 15274332
Free article
Chemotaxis and chemokinesis of malignant mesothelioma cells to multiple growth factors
Zhiwen Liu et al. Anticancer Res. 2004 May-Jun.
Free article
Abstract
Background: Chemotaxis is defined as directional cell movement of cells towards concentration gradients of solubilized attractants, whereas chemokinesis is defined as random cell movement in the absence of chemoattractant gradients. Since tumor cell motility plays an important role in the process of tumor invasion and metastasis, we investigated these two distinct motile behaviors in highly invasive tumor, malignant mesothelioma.
Materials and methods: Chemotaxis and chemokinesis of mesothelioma cells were assayed using Boyden chambers fitted with filters coated with collagen type IV and different growth factors and cytokines were used as chemoattractants.
Results: We found that growth factors such as epidermal growth factor, transforming growth factor-alpha, amphiregulin, heparin-binding epidermal growth factor-like growth factor, beta-cellulin, insulin-like growth factor-I, insulin-like growth factor-II and stem cell factor stimulated directional (chemotactic) and/or random (chemokinetic) motility in all mesothelioma cell lines tested, whereas none of acidic fibroblast growth factor, basic fibroblast growth factor, granulocyte-macrophage colony-stimulating factor or interleukin-6 induced migration in the same mesothelioma cells.
Conclusion: These findings provide evidence that: (i) multiple growth factors can induce chemotaxis and chemokinesis in malignant mesothelioma cell lines, and (ii) may contribute to our understanding of the highly invasive behavior of malignant mesotheliomas in vivo.
Similar articles
- Epidermal growth factor (EGF) promotes chemomigration of a human prostate tumor cell line, and EGF immunoreactive proteins are present at sites of metastasis in the stroma of lymph nodes and medullary bone.
Rajan R, Vanderslice R, Kapur S, Lynch J, Thompson R, Djakiew D. Rajan R, et al. Prostate. 1996 Jan;28(1):1-9. doi: 10.1002/(SICI)1097-0045(199601)28:1<1::AID-PROS1>3.0.CO;2-L. Prostate. 1996. PMID: 8545275 - Tumor cell motility.
Liotta LA, Stracke ML, Aznavoorian SA, Beckner ME, Schiffmann E. Liotta LA, et al. Semin Cancer Biol. 1991 Apr;2(2):111-4. Semin Cancer Biol. 1991. PMID: 1912521 Review. - [Chemotaxis in normal and pathologic conditions].
Ermakova NG. Ermakova NG. Arkh Patol. 1983;45(7):79-85. Arkh Patol. 1983. PMID: 6354145 Review. Russian.
Cited by
- LPA1-mediated inhibition of CXCR4 attenuates CXCL12-induced signaling and cell migration.
Hong JM, Lee JW, Seen DS, Jeong JY, Huh WK. Hong JM, et al. Cell Commun Signal. 2023 Sep 25;21(1):257. doi: 10.1186/s12964-023-01261-7. Cell Commun Signal. 2023. PMID: 37749552 Free PMC article. - HAPLN1 matrikine: a bone marrow homing factor linked to poor outcomes in patients with MM.
Chang HY, Huynh M, Roopra A, Callander NS, Miyamoto S. Chang HY, et al. Blood Adv. 2023 Nov 28;7(22):6859-6872. doi: 10.1182/bloodadvances.2023010139. Blood Adv. 2023. PMID: 37647592 Free PMC article. - A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT-0701 MAPS phase 3 trial.
Maille E, Levallet J, Dubois F, Antoine M, Danel C, Creveuil C, Mazieres J, Margery J, Greillier L, Gounant V, Moro-Sibilot D, Molinier O, Léna H, Monnet I, Bergot E, Langlais A, Morin F, Scherpereel A, Zalcman G, Levallet G. Maille E, et al. Int J Cancer. 2022 Jun 1;150(11):1889-1904. doi: 10.1002/ijc.33997. Epub 2022 Mar 16. Int J Cancer. 2022. PMID: 35262190 Free PMC article. Clinical Trial. - Automated platform for cell selection and separation based on four-dimensional motility and matrix degradation.
Nowotarski HL , Attayek PJ , Allbritton NL . Nowotarski HL , et al. Analyst. 2020 Apr 7;145(7):2731-2742. doi: 10.1039/c9an02224d. Epub 2020 Feb 21. Analyst. 2020. PMID: 32083265 Free PMC article. - Facilitated recruitment of mesenchymal stromal cells by bone marrow concentrate and platelet rich plasma.
Holmes HL, Wilson B, Goerger JP, Silverberg JL, Cohen I, Zipfel WR, Fortier LA. Holmes HL, et al. PLoS One. 2018 Mar 22;13(3):e0194567. doi: 10.1371/journal.pone.0194567. eCollection 2018. PLoS One. 2018. PMID: 29566102 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical